Cellebrite DI Statistics
Total Valuation
Cellebrite DI has a market cap or net worth of $3.03 billion. The enterprise value is $2.51 billion.
| Market Cap | 3.03B |
| Enterprise Value | 2.51B |
Important Dates
The next confirmed earnings date is Thursday, November 12, 2026, before market open.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cellebrite DI has 250.79 million shares outstanding. The number of shares has increased by 9.33% in one year.
| Current Share Class | 250.79M |
| Shares Outstanding | 250.79M |
| Shares Change (YoY) | +9.33% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 1.69% |
| Owned by Institutions (%) | 37.31% |
| Float | 99.28M |
Valuation Ratios
The trailing PE ratio is 52.70 and the forward PE ratio is 19.72. Cellebrite DI's PEG ratio is 1.12.
| PE Ratio | 52.70 |
| Forward PE | 19.72 |
| PS Ratio | 5.90 |
| Forward PS | 5.05 |
| PB Ratio | 5.64 |
| P/TBV Ratio | 10.23 |
| P/FCF Ratio | 21.05 |
| P/OCF Ratio | 19.26 |
| PEG Ratio | 1.12 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.03, with an EV/FCF ratio of 17.42.
| EV / Earnings | 43.13 |
| EV / Sales | 4.88 |
| EV / EBITDA | 32.03 |
| EV / EBIT | 44.97 |
| EV / FCF | 17.42 |
Financial Position
The company has a current ratio of 1.62, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.62 |
| Quick Ratio | 1.52 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.27 |
| Debt / FCF | 0.16 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.42% and return on invested capital (ROIC) is 39.04%.
| Return on Equity (ROE) | 12.42% |
| Return on Assets (ROA) | 3.92% |
| Return on Invested Capital (ROIC) | 39.04% |
| Return on Capital Employed (ROCE) | 8.87% |
| Weighted Average Cost of Capital (WACC) | 10.40% |
| Revenue Per Employee | $400,225 |
| Profits Per Employee | $45,328 |
| Employee Count | 1,285 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 9.78 |
Taxes
In the past 12 months, Cellebrite DI has paid $16.62 million in taxes.
| Income Tax | 16.62M |
| Effective Tax Rate | 22.05% |
Stock Price Statistics
The stock price has decreased by -31.95% in the last 52 weeks. The beta is 1.13, so Cellebrite DI's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | -31.95% |
| 50-Day Moving Average | 11.39 |
| 200-Day Moving Average | 13.55 |
| Relative Strength Index (RSI) | 59.78 |
| Average Volume (20 Days) | 1,907,986 |
Short Selling Information
The latest short interest is 8.08 million, so 3.22% of the outstanding shares have been sold short.
| Short Interest | 8.08M |
| Short Previous Month | 9.47M |
| Short % of Shares Out | 3.22% |
| Short % of Float | 8.14% |
| Short Ratio (days to cover) | 2.93 |
Income Statement
In the last 12 months, Cellebrite DI had revenue of $514.29 million and earned $58.25 million in profits. Earnings per share was $0.23.
| Revenue | 514.29M |
| Gross Profit | 426.66M |
| Operating Income | 55.86M |
| Pretax Income | 75.38M |
| Net Income | 58.25M |
| EBITDA | 78.43M |
| EBIT | 55.86M |
| Earnings Per Share (EPS) | $0.23 |
Balance Sheet
The company has $442.53 million in cash and $23.23 million in debt, with a net cash position of $522.49 million or $2.08 per share.
| Cash & Cash Equivalents | 442.53M |
| Total Debt | 23.23M |
| Net Cash | 522.49M |
| Net Cash Per Share | $2.08 |
| Equity (Book Value) | 538.10M |
| Book Value Per Share | 2.15 |
| Working Capital | 225.47M |
Cash Flow
In the last 12 months, operating cash flow was $157.56 million and capital expenditures -$13.39 million, giving a free cash flow of $144.17 million.
| Operating Cash Flow | 157.56M |
| Capital Expenditures | -13.39M |
| Depreciation & Amortization | 22.56M |
| Net Borrowing | n/a |
| Free Cash Flow | 144.17M |
| FCF Per Share | $0.57 |
Margins
Gross margin is 82.96%, with operating and profit margins of 10.86% and 11.43%.
| Gross Margin | 82.96% |
| Operating Margin | 10.86% |
| Pretax Margin | 14.66% |
| Profit Margin | 11.43% |
| EBITDA Margin | 15.25% |
| EBIT Margin | 10.86% |
| FCF Margin | 28.03% |
Dividends & Yields
Cellebrite DI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -9.33% |
| Shareholder Yield | -9.33% |
| Earnings Yield | 1.90% |
| FCF Yield | 4.75% |
Analyst Forecast
The average price target for Cellebrite DI is $15.36, which is 26.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.36 |
| Price Target Difference | 26.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 15.79% |
| EPS Growth Forecast (3Y) | 14.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cellebrite DI has an Altman Z-Score of 5.88 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.88 |
| Piotroski F-Score | 4 |